Home Application Market Business Products Research Strategic Partnerships Investor Relations Contact


The nutraceutical market worldwide, after having experienced exponential growth over the past few years, is now witnessing a slump. A market research report produced by Global Industry Analysts, Inc.  projected that the worldwide nutraceutical market would reach US$250 billion by 2018, defining that market as "Dietary Supplements (Vitamins, Minerals, Herbals, Non-Herbals, & Others), and Functional Foods & Beverages.

The way to beat this trend is to search for and acquire novel drugs, or to find new ways to apply already existing drugs. Alterola is working within one of the few health care niches that experience two-figure growth rates; a momentum the company will draw on for the benefit of customers and the shareholders of the company.

Global Industry Analysts, Inc. has also completed a comprehensive global report on the gums markets. The global market for gums is forecast to reach US$23.1 billion by the year 2017, buoyed by growing demand for medicated and sugar free gum products, particularly from the growing tribe of health conscious consumers.

Alterola Biotech’ main products are functional chewing gum. Koncept Analytics has forecasted an uninterrupted 15% increase in the market for well-being chewing gum, rapidly expanding this $700 million market (Gale Goliath) for at least the next 5 years. The intellectual properties of Alterola will if successful bring aggregated revenues in the billions of dollars when brought to market!

Presently Alterola Biotech is focused on nutrition and health chewing gum with natural based ingredients but we intend on expanding the product line with gums having medical effects such as painkillers and antihistamine medications with gum delivery. Even a miniscule share of the $24.3bn (Datamonitor) painkiller market will lead to huge revenue. As 40% of all American adults have trouble swallowing their painkillers, Alterola believes that even a modest 1% share of the over-the-counter painkiller market is within easy reach during the first three years after development of such chewing gum.

"Alterola is working within one of the few health care niches that experience two-figure growth rates"
[an error occurred while processing this directive]